Related Experiment Video
Updated: Jan 19, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Resolution of Crohn's disease
Heike Schmitt1, Clemens Neufert1, Markus F Neurath1
1First Department of Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Ulmenweg 18, 91054, Erlangen, Germany.
This review explores how the body actively resolves inflammation in Crohn's disease (CD), a chronic gastrointestinal condition. Understanding these resolution mechanisms is key to developing new treatments for inflammatory bowel disease (IBD).
Area of Science:
- Gastroenterology
- Immunology
- Molecular Biology
Background:
- Crohn's disease (CD) is a major form of inflammatory bowel disease (IBD) characterized by chronic gastrointestinal inflammation.
- Immune cell infiltration and pro-inflammatory mediator production drive the inflammatory cascade in CD.
- Inflammation involves induction, peak, and resolution phases, with resolution being an active, coordinated process.
Purpose of the Study:
- To review the mechanisms, pathways, and mediators involved in the active resolution of inflammation in Crohn's disease.
- To highlight the importance of understanding the resolution phase for potential therapeutic strategies in IBD.
Main Methods:
- Literature review focusing on inflammatory and resolution mechanisms in CD.
- Analysis of research on immune cell involvement and mediator roles in intestinal inflammation.
- Synthesis of current understanding of active inflammation resolution processes.
Main Results:
- The resolution of inflammation is an active and tightly regulated process, not merely passive cessation.
- Specific lipid and protein mediators play crucial roles in initiating and sustaining the inflammatory cascade.
- Understanding these mediators and pathways is essential for comprehending the resolution phase in CD.
Conclusions:
- The resolution of inflammation in Crohn's disease is an active, multi-step process.
- Identifying key mediators and pathways offers potential targets for novel IBD therapies.
- Further research into inflammation resolution mechanisms is critical for advancing CD treatment.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

